Abstract:Objective: To determine the expression and diagnostic value of peripheral blood lymphocytes and functional activation status in non-Hodgkin lymphoma with hemophagocytic lymphohistiocytosis (NHL-HLH) . Methods: We retrospectively analyzed clinical data from 30 newly diagnosed NHL-HLH patients admitted to Jiangsu Province Hospital from September 2022 to September 2023. We assessed peripheral blood lymphocytes and activation status by flow cytometry. Forty newly diagnosed patients with NHL who received treatment at our hospital during the same period and had lymphocyte and functional activation indexes were selected as the control group. The differences in relative and absolute lymphocyte counts and functional activation indexes between the two groups were compared. The optimal cutoff values for continuous variables were calculated from the receiver operating characteristic curve and logistic regression analysis was used to evaluate the risk factors in NHL patients with HLH. Results: A total of 30 NHL-HLH patients were evaluated, including 12 T-cell lymphoma and 18 B-cell lymphoma patients. Forty individuals were in the control group, which included 19 T-cell lymphoma and 21 B-cell lymphoma patients. The absolute counts of CD3(+) T, CD4(+) T, CD8(+) T, and NK cells, along with the relative count of NK cells, were significantly lower in the HLH group compared with that in the control group (all P values<0.01) . The expression of CD38 and HLA-DR on CD8(+) T-cell activated subgroups was significantly higher in the NHL-HLH group compared with that in the control group (CD8(+)CD38(+)/CD8(+) T expression median: 57.4% vs 21.5%, P<0.001; CD8(+)CD38(+)/CD8(+) T expression median: 49.7% vs 33.5%, P=0.028, respectively) . In addition, CD28 expression on CD4(+) and CD8(+) T cells was significantly higher in NHL-HLH patients (P<0.01) . ROC curve and multivariate logistic regression analyses revealed that absolute NK cell count ≤72.0 cells/μl, CD4(+)CD28(+)/CD4(+) T >94.2%, and CD8(+)CD28(+)/CD8(+) T >38.4% were risk factors for predicting the occurrence of NHL-HLH patients. The sensitivity and specificity of the regression model were 86.7% and 86.1%, respectively, with an area under the curve of 0.94 (P<0.001) . Conclusions: In NHL patients with HLH, there was a significant reduction in the absolute number of peripheral blood lymphocyte subpopulations, whereas T-cell function was notably activated. Specifically, absolute counts of NK cells ≤72.0 cells/μl, CD4(+)CD28(+)/CD4(+) T >94.2%, and CD8(+)CD28(+)/CD8(+) T >38.4% were identified as risk factors for predicting the development of NHL-HLH patients. This will assist in early clinical diagnosis and treatment.

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

A degranulation assay using Vγ9Vδ2 T cells for the rapid diagnosis of familial hemophagocytic syndromes

High Percentages of Peripheral Blood T-cell Activation in Childhood Hodgkin's Lymphoma Are Associated with Inferior Outcome.

Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children

Comparison of Th1/Th2 Cytokine Profiles Between Primary and Secondary Haemophagocytic Lymphohistiocytosis

Comprehensive Evaluation of Immune Dysregulation and Altered Cytotoxic Markers in Secondary Hemophagocytic Lymphohistiocytosis (Shlh)

[Diagnostic Significance of Th1/Th2 Cytokine Pattern in Childhood Hemophagocytic Lymphohistiocytosis].

[Expression and diagnostic value of lymphocyte subsets and activation status in non-Hodgkin's lymphoma-associated hemophagocytic lymphohistiocytosis]

Diagnostic Accuracy of a Specific Cytokine Pattern in Hemophagocytic Lymphohistiocytosis in Children.

Studies on the Early Diagnosis and the Intervention for Children with Hemophagocytic Lymphohistiocy-Tosis

Diagnostic accuracy of bone marrow blood evaluation in haemophagocytic lymphohistiocytosis paediatric patients

Comprehensive evaluation of immune dysregulation in secondary hemophagocytic lymphohistiocytosis

Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children

Hemophagocytic lymphohistiocytosis: A disorder of T cell activation, immune regulation, and distinctive immunopathology

Diagnostic Guidelines for Familial Hemophagocytic Lymphohistiocytosis Revisited

Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)

Clinical Characteristics of Extranodal NK/T-cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

Clinical characteristics of hemophagocytic lymphohistiocytosis

History of Hemophagocytic Lymphohistiocytosis

Allogeneic stem cell transplant in primary hemophagocytic lymphohistiocytosis - a single-center experience

Advances in Hemophagocytic Lymphohistiocytosis: Pathogenesis, Early Diagnosis/Differential Diagnosis, and Treatment